{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T14:49:15Z","timestamp":1777042155734,"version":"3.51.4"},"reference-count":59,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diseases"],"abstract":"<jats:p>Background\/Objectives: Hepatic diseases frequently present with ocular manifestations that aid diagnosis, provide prognostic data, and guide therapy. Despite the clear utility of the liver\u2013eye axis, the literature lacks reviews that categorize these manifestations by etiology. This review evaluates current evidence to identify ocular findings that serve as clinical tools for diagnosis, prognosis, and therapeutic monitoring of hepatic pathologies. Methods: A narrative review was conducted using PubMed and Google Scholar to identify English-language articles addressing ocular manifestations associated with liver disease. The primary search encompassed publications from 2000 to 2025, with inclusion of select foundational works published prior to 2000 when they represented seminal studies establishing diagnostic criteria, pathophysiological mechanisms, or natural history data not superseded by subsequent research. Search terms included combinations of liver, hepatic, hepatitis, cirrhosis, cholestasis, eye, ocular, retina, cornea, sclera, conjunctiva, ophthalmic manifestations, and specific disease names. All study designs were eligible. Society guidelines, systematic reviews, and studies from high-impact journals were prioritized. The final selection comprised 59 references representing the most authoritative sources across the spectrum of hepatic conditions. Results: A spectrum of ocular findings linked to distinct hepatic conditions was identified. Manifestations with established clinicopathologic associations were categorized into congenital and acquired etiologies. Congenital liver pathologies included metabolic disorders (Wilson disease, galactosemia, lysosomal storage disorders) and syndromic\/genetic causes (Alagille syndrome, hereditary hemochromatosis). Acquired liver diseases encompassed infectious (hepatitis B\/C), drug-induced and iatrogenic (interferon, immune checkpoint inhibitors), nutritional (vitamin A deficiency), neoplastic (metastatic hepatocellular carcinoma), and cirrhotic causes. Conclusions: Specific ocular signs raise clinical suspicion for underlying liver disease and warrant targeted hepatic evaluation. Recognizing these associations facilitates earlier diagnosis and improves outcomes. Systematic screening for these signs is supported in at-risk populations, and prospective validation studies should establish their sensitivity and specificity.<\/jats:p>","DOI":"10.3390\/diseases14050152","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T12:29:11Z","timestamp":1777033751000},"page":"152","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ocular Clues to Liver Disease: A Strategic Diagnostic Lens"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-6706-0880","authenticated-orcid":false,"given":"Muhammad","family":"Dahshan","sequence":"first","affiliation":[{"name":"Joan C. Edwards School of Medicine, Marshall University, Huntington, WV 25701, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4156-5654","authenticated-orcid":false,"given":"Hassan","family":"Dahshan","sequence":"additional","affiliation":[{"name":"Joan C. Edwards School of Medicine, Marshall University, Huntington, WV 25701, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayhan","family":"Basoglu","sequence":"additional","affiliation":[{"name":"Independent Researcher, Charleston, WV 25304, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huseyin","family":"Kadikoy","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Charleston Area Medical Center, Charleston, WV 25304, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,4,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1186\/s12967-023-04543-3","article-title":"Insights into the Liver-Eyes Connections, from Epidemiological, Mechanical Studies to Clinical Translation","volume":"21","author":"Wu","year":"2023","journal-title":"J. Transl. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.dld.2019.11.009","article-title":"Pediatric Liver Diseases and Ocular Changes: What Hepatologists and Ophthalmologists Should Know and Share with Each Other","volume":"52","author":"Vitiello","year":"2020","journal-title":"Dig. Liver Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.survophthal.2016.11.002","article-title":"Periocular, Periorbital, and Orbital Pathology in Liver Disease","volume":"62","author":"Carroll","year":"2017","journal-title":"Surv. Ophthalmol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/eye.1992.75","article-title":"The Eye and Liver Disorders","volume":"6","year":"1992","journal-title":"Eye"},{"key":"ref_5","first-page":"4","article-title":"Managing Eye Health in Young Children","volume":"23","author":"Baiyeroju","year":"2010","journal-title":"Community Eye Health"},{"key":"ref_6","first-page":"1005","article-title":"Novel Mutations in the FOXC1 Gene in Japanese Patients with Axenfeld-Rieger Syndrome","volume":"13","author":"Fuse","year":"2007","journal-title":"Mol. Vis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1002\/hep.32805","article-title":"A Multidisciplinary Approach to the Diagnosis and Management of Wilson Disease: 2022 Practice Guidance on Wilson Disease from the American Association for the Study of Liver Diseases","volume":"77","author":"Schilsky","year":"2025","journal-title":"Hepatology"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1056\/NEJMra1903585","article-title":"Current and Emerging Issues in Wilson\u2019s Disease","volume":"389","author":"Roberts","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0140-6736(07)60196-2","article-title":"Wilson\u2019s Disease","volume":"369","author":"Ala","year":"2007","journal-title":"Lancet"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/S2468-1253(22)00004-8","article-title":"Investigation and Management of Wilson\u2019s Disease: A Practical Guide from the British Association for the Study of the Liver","volume":"7","author":"Shribman","year":"2022","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Chevalier, K., Mauget-Fa\u00ffsse, M., Vasseur, V., Azar, G., Obadia, M.A., and Poujois, A. (2022). Eye Involvement in Wilson\u2019s Disease: A Review of the Literature. J. Clin. Med., 11.","DOI":"10.3390\/jcm11092528"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.metabol.2018.01.025","article-title":"Hereditary Galactosemia","volume":"83","author":"Demirbas","year":"2018","journal-title":"Metabolism"},{"key":"ref_13","unstructured":"Adam, M.P., Feldman, J., Mirzaa, G.M., Pagon, R.A., and Wallace, S.E. (2025, December 15). Classic Galactosemia and Clinical Variant Galactosemia, GeneReviews\u00ae, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1518\/."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s10545-016-9990-5","article-title":"International Clinical Guideline for the Management of Classical Galactosemia: Diagnosis, Treatment, and Follow-Up","volume":"40","author":"Welling","year":"2017","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ymgme.2015.12.009","article-title":"Peroxisome Biogenesis Disorders in the Zellweger Spectrum: An Overview of Current Diagnosis, Clinical Manifestations, and Treatment Guidelines","volume":"117","author":"Braverman","year":"2016","journal-title":"Mol. Genet. Metab."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s13023-015-0368-9","article-title":"Zellweger Spectrum Disorders: Clinical Overview and Management Approach","volume":"10","author":"Klouwer","year":"2015","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.ophtha.2023.07.026","article-title":"Zellweger Spectrum Disorder: Ophthalmic Findings from a New Natural History Study Cohort and Scoping Literature Review","volume":"130","author":"Yergeau","year":"2023","journal-title":"Ophthalmology"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/gim.2017.7","article-title":"Consensus Recommendation for a Diagnostic Guideline for Acid Sphingomyelinase Deficiency","volume":"19","author":"McGovern","year":"2017","journal-title":"Genet. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.ymgme.2012.03.012","article-title":"Recommendations for the Diagnosis and Management of Niemann-Pick Disease Type C: An Update","volume":"106","author":"Patterson","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1007\/s10072-012-1155-1","article-title":"Vertical Supranuclear Gaze Palsy in Niemann-Pick Type C Disease","volume":"33","author":"Salsano","year":"2012","journal-title":"Neurol. Sci."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"v4","DOI":"10.1093\/rheumatology\/ker394","article-title":"Overview of the Mucopolysaccharidoses","volume":"50","author":"Muenzer","year":"2011","journal-title":"Rheumatology"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.survophthal.2005.11.007","article-title":"Mucopolysaccharidoses and the Eye","volume":"51","author":"Ashworth","year":"2006","journal-title":"Surv. Ophthalmol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1056\/NEJMra1910234","article-title":"Alpha1-Antitrypsin Deficiency","volume":"382","author":"Strnad","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_24","first-page":"668","article-title":"The Diagnosis and Management of Alpha-1 Antitrypsin Deficiency in the Adult","volume":"3","author":"Sandhaus","year":"2016","journal-title":"Chronic Obstr. Pulm. Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s10545-016-9979-0","article-title":"Guidelines for the Diagnosis and Management of Cystathionine Beta-Synthase Deficiency","volume":"40","author":"Morris","year":"2017","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_26","first-page":"1","article-title":"The Natural History of Homocystinuria Due to Cystathionine Beta-Synthase Deficiency","volume":"37","author":"Mudd","year":"1985","journal-title":"Am. J. Hum. Genet."},{"key":"ref_27","unstructured":"Adam, M.P., Feldman, J., Mirzaa, G.M., Pagon, R.A., and Wallace, S.E. (2025, December 15). Alagille Syndrome, GeneReviews\u00ae, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1273\/."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1167\/iovs.62.7.27","article-title":"Characterization of the Spectrum of Ophthalmic Changes in Patients with Alagille Syndrome","volume":"62","author":"Igelman","year":"2021","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Suchy, F.J., Sokol, R.J., and Balistreri, W.F. (2014). Alagille Syndrome. Liver Disease in Children, Cambridge University Press. [4th ed.].","DOI":"10.1017\/CBO9781139012102"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.24330","article-title":"Diagnosis and Management of Hemochromatosis: 2011 Practice Guideline by the American Association for the Study of Liver Diseases","volume":"54","author":"Bacon","year":"2011","journal-title":"Hepatology"},{"key":"ref_31","first-page":"1123","article-title":"Treatment and Non-Treatment Related Ocular Manifestations in Patients with Chronic Hepatitis B or C","volume":"17","author":"Tsoumani","year":"2013","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/00055735-200212000-00014","article-title":"Ocular Manifestations of Hepatitis C Virus Infection","volume":"13","author":"Zegans","year":"2002","journal-title":"Curr. Opin. Ophthalmol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.ajo.2007.07.028","article-title":"Hepatitis C and Ocular Surface Disease","volume":"144","author":"Jacobi","year":"2007","journal-title":"Am. J. Ophthalmol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/jvh.12135","article-title":"Interferon-Associated Retinopathy During the Treatment of Chronic Hepatitis C: A Systematic Review","volume":"20","author":"Raza","year":"2013","journal-title":"J. Viral Hepat."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1001\/archopht.1996.01100130718014","article-title":"Interferon Alfa Induces Leukocyte Capillary Trapping in Rat Retinal Microcirculation","volume":"114","author":"Nishiwaki","year":"1996","journal-title":"Arch. Ophthalmol."},{"key":"ref_36","first-page":"309","article-title":"Retinal Complications During Interferon Therapy for Chronic Hepatitis C","volume":"91","author":"Kawano","year":"1996","journal-title":"Am. J. Gastroenterol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.ophtha.2010.03.063","article-title":"Interferon Alfa-Associated Anterior Ischemic Optic Neuropathy","volume":"118","author":"Fraunfelder","year":"2011","journal-title":"Ophthalmology"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"4073","DOI":"10.1200\/JCO.21.01440","article-title":"Management of Immune-Related Adverse Events in Patients Treated with Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update","volume":"39","author":"Schneider","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1097\/IAE.0000000000002181","article-title":"Checkpoint Inhibitor Immune Therapy: Systemic Indications and Ophthalmic Side Effects","volume":"38","author":"Dalvin","year":"2018","journal-title":"Retina"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.ophtha.2020.11.001","article-title":"Ophthalmic Immune-Related Adverse Events after Anti-CTLA-4 or PD-1 Therapy Recorded in the American Academy of Ophthalmology IRIS Registry","volume":"128","author":"Sun","year":"2021","journal-title":"Ophthalmology"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1080\/14737140.2017.1296765","article-title":"Immune-Related Ocular Toxicities in Solid Tumor Patients Treated with Immune Checkpoint Inhibitors: A Systematic Review","volume":"17","author":"Oweira","year":"2017","journal-title":"Expert Rev. Anticancer Ther."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"58709","DOI":"10.18632\/oncotarget.17634","article-title":"Ocular Toxicities Associated with Targeted Anticancer Agents: An Analysis of Clinical Data with Management Suggestions","volume":"8","author":"Fu","year":"2017","journal-title":"Oncotarget"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"16188","DOI":"10.1038\/s41598-025-00004-7","article-title":"Characterization of Adverse Reactions to Four Common Targeted Drugs for Hepatocellular Carcinoma in WHO-VigiAccess","volume":"15","author":"Wang","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/MPG.0000000000002443","article-title":"Nutrition Support of Children with Chronic Liver Diseases: A Joint Position Paper of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition","volume":"69","author":"Mouzaki","year":"2019","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1093\/jn\/138.10.1835","article-title":"Vitamin A Deficiency and Clinical Disease: An Historical Overview","volume":"138","author":"Sommer","year":"2008","journal-title":"J. Nutr."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1097\/IOP.0b013e31829f3a57","article-title":"Orbital Metastasis from Hepatocellular Carcinoma: Report of 6 Cases","volume":"30","author":"Eldesouky","year":"2014","journal-title":"Ophthalmic Plast. Reconstr. Surg."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1076\/opep.9.1.35.1718","article-title":"Metastatic Orbital Tumors in Japan: A Review of the Literature","volume":"9","author":"Amemiya","year":"2002","journal-title":"Ophthalmic Epidemiol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1001\/archopht.116.7.942","article-title":"Hepatocellular Carcinoma Metastatic to the Orbit","volume":"116","author":"Font","year":"1998","journal-title":"Arch. Ophthalmol."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Gifford, F.J., Moroni, F., Farrah, T.E., Hetherington, K., MacGillivray, T.J., Hayes, P.C., Dhaun, N., and Fallowfield, J.A. (2020). The Eye as a Non-Invasive Window to the Microcirculation in Liver Cirrhosis: A Prospective Pilot Study. J. Clin. Med., 9.","DOI":"10.3390\/jcm9103332"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1056\/NEJMra2412865","article-title":"Metabolic Dysfunction-Associated Steatotic Liver Disease","volume":"393","author":"Targher","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/s41575-025-01045-z","article-title":"Metabolic Dysfunction-Associated Steatotic Liver Disease: A Condition of Heterogeneous Metabolic Risk Factors, Mechanisms and Comorbidities Requiring Holistic Treatment","volume":"22","author":"Byrne","year":"2025","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"102424","DOI":"10.1016\/j.eclinm.2024.102424","article-title":"Associations of Severe Liver Diseases with Cataract Using Data from UK Biobank: A Prospective Cohort Study","volume":"68","author":"Chen","year":"2024","journal-title":"eClinicalMedicine"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"104271","DOI":"10.1016\/j.numecd.2025.104271","article-title":"Association of Metabolic Dysfunction-Associated Fatty Liver Disease with Microvascular Complications in Adults with Prediabetes","volume":"36","author":"Xie","year":"2025","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1097\/MEG.0000000000000900","article-title":"Nonalcoholic Fatty Liver Disease Can Be Predicted by Retinal Vascular Changes in Patients with Obesity Without Hypertension or Diabetes","volume":"29","year":"2017","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s00535-014-1024-1","article-title":"The Association Between Retinal Microvascular Changes, Metabolic Risk Factors, and Liver Histology in Pediatric Patients with Non-Alcoholic Fatty Liver Disease (NAFLD)","volume":"50","author":"Liccardo","year":"2015","journal-title":"J. Gastroenterol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s12072-015-9607-3","article-title":"Association Between Retinal Artery Lesions and Nonalcoholic Fatty Liver Disease","volume":"9","author":"Yang","year":"2015","journal-title":"Hepatol. Int."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Xie, X., Feng, K., Wang, J., Zhu, Y., Qiu, Y., Dai, Y., Jiang, Y., Jiang, J., Jiang, H., and Shi, Y. (2022). Comprehensive Visual Electrophysiological Measurements Discover Crucial Changes Caused by Alcohol Addiction in Humans: Clinical Values in Early Prevention of Alcoholic Vision Decline. Front. Neural Circuits, 16.","DOI":"10.3389\/fncir.2022.912883"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3350\/cmh.2017.0021","article-title":"Bilateral Optic Neuropathy Related to Severe Anemia in a Patient with Alcoholic Cirrhosis: A Case Report and Review of the Literature","volume":"24","author":"Selton","year":"2018","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/hep.30866","article-title":"Diagnosis and Treatment of Alcohol-Associated Liver Diseases: 2019 Practice Guidance from the American Association for the Study of Liver Diseases","volume":"71","author":"Crabb","year":"2020","journal-title":"Hepatology"}],"container-title":["Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-9721\/14\/5\/152\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T12:53:53Z","timestamp":1777035233000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-9721\/14\/5\/152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,24]]},"references-count":59,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["diseases14050152"],"URL":"https:\/\/doi.org\/10.3390\/diseases14050152","relation":{},"ISSN":["2079-9721"],"issn-type":[{"value":"2079-9721","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,24]]}}}